BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Feb 14, 2014

Total Value: $572M (89.0% shares, 11.0% debt)

Holdings (26)

LGND LIGAND PHARMACEUTICALS INC 24.2%

Value $138M Shares 2,626,160 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 19.4%

Value $111M Shares 9,575,649 Est. Cost — Unrealized —

— EXELIXIS INC 8.8%

Value $50.08M Shares 40,735,000 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 7.9%

Value $45.14M Shares 7,796,516 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 6.6%

Value $37.84M Shares 7,553,089 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 5.6%

Value $32.19M Shares 1,090,478 Est. Cost — Unrealized —

— TARGACEPT INC 4.5%

Value $25.61M Shares 6,171,669 Est. Cost — Unrealized —

— RIGEL PHARMACEUTICALS INC 4.0%

Value $22.64M Shares 7,943,215 Est. Cost — Unrealized —

— ONCOTHYREON INC 2.8%

Value $15.84M Shares 9,001,778 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 2.7%

Value $15.4M Shares 2,368,905 Est. Cost — Unrealized —

— QLT INC 2.3%

Value $13.2M Shares 2,370,263 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 2.2%

Value $12.53M Shares 12,000,000 Est. Cost — Unrealized —

— RECEPTOS INC 1.6%

Value $9.181M Shares 316,692 Est. Cost — Unrealized —

— REGADO BIOSCIENCES INC 1.4%

Value $7.914M Shares 1,659,091 Est. Cost — Unrealized —

— FIVE PRIME THERAPEUTICS INC 1.4%

Value $7.74M Shares 461,000 Est. Cost — Unrealized —

XNCR XENCOR INC 1.3%

Value $7.495M Shares 820,000 Est. Cost — Unrealized —

— ARQULE INC 1.1%

Value $6.072M Shares 2,824,387 Est. Cost — Unrealized —

— PALATIN TECHNOLOGIES INC 0.7%

Value $3.817M Shares 5,200,000 Est. Cost — Unrealized —

— BIND THERAPEUTICS INC 0.4%

Value $2.264M Shares 150,000 Est. Cost — Unrealized —

— MIRATI THERAPEUTICS INC 0.4%

Value $2.234M Shares 134,317 Est. Cost — Unrealized —

— SOPHIRIS BIO INC 0.4%

Value $2.22M Shares 600,000 Est. Cost — Unrealized —

— REGULUS THERAPEUTICS INC 0.3%

Value $1.727M Shares 233,689 Est. Cost — Unrealized —

— KINDRED BIOSCIENCES INC 0.1%

Value $577K Shares 51,788 Est. Cost — Unrealized —

— TRANSCEPT PHARMACEUTICALS IN 0.1%

Value $504K Shares 150,000 Est. Cost — Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 0.0%

Value $47,000 Shares 196,996 Est. Cost — Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.0%

Value $17,000 Shares 559,624 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS INC	2,626,160	$138M	24.2%	—	—	COM NEW	53220K504
IRWD	IRONWOOD PHARMACEUTICALS INC	9,575,649	$111M	19.4%	—	—	COM CL A	46333X108
—	EXELIXIS INC	40,735,000	$50.08M	8.8%	—	—	NOTE 4.250% 8/1	30161QAC8
—	CHEMOCENTRYX INC	7,796,516	$45.14M	7.9%	—	—	COM	16383L106
—	ARRAY BIOPHARMA INC	7,553,089	$37.84M	6.6%	—	—	COM	04269X105
—	ONCOMED PHARMACEUTICALS INC	1,090,478	$32.19M	5.6%	—	—	COM	68234X102
—	TARGACEPT INC	6,171,669	$25.61M	4.5%	—	—	COM	87611R306
—	RIGEL PHARMACEUTICALS INC	7,943,215	$22.64M	4.0%	—	—	COM NEW	766559603
—	ONCOTHYREON INC	9,001,778	$15.84M	2.8%	—	—	COM	682324108
CYTK	CYTOKINETICS INC	2,368,905	$15.4M	2.7%	—	—	COM NEW	23282W605
—	QLT INC	2,370,263	$13.2M	2.3%	—	—	COM	746927102
—	ARRAY BIOPHARMA INC	12,000,000	$12.53M	2.2%	—	—	NOTE 3.000% 6/0	04269XAA3
—	RECEPTOS INC	316,692	$9.181M	1.6%	—	—	COM	756207106
—	REGADO BIOSCIENCES INC	1,659,091	$7.914M	1.4%	—	—	COM	75874Q107
—	FIVE PRIME THERAPEUTICS INC	461,000	$7.74M	1.4%	—	—	COM	33830X104
XNCR	XENCOR INC	820,000	$7.495M	1.3%	—	—	COM	98401F105
—	ARQULE INC	2,824,387	$6.072M	1.1%	—	—	COM	04269E107
—	PALATIN TECHNOLOGIES INC	5,200,000	$3.817M	0.7%	—	—	COM PAR $ .01	696077403
—	BIND THERAPEUTICS INC	150,000	$2.264M	0.4%	—	—	COM	05548N107
—	MIRATI THERAPEUTICS INC	134,317	$2.234M	0.4%	—	—	COM	60468T105
—	SOPHIRIS BIO INC	600,000	$2.22M	0.4%	—	—	COM NEW	83578Q209
—	REGULUS THERAPEUTICS INC	233,689	$1.727M	0.3%	—	—	COM	75915K101
—	KINDRED BIOSCIENCES INC	51,788	$577K	0.1%	—	—	COM	494577109
—	TRANSCEPT PHARMACEUTICALS IN	150,000	$504K	0.1%	—	—	COM	89354M106
AGIO	AGIOS PHARMACEUTICALS INC	196,996	$47,000	0.0%	—	—	COM	00847X104
—	ANTHERA PHARMACEUTICALS INC	559,624	$17,000	0.0%	—	—	COM NEW	03674U201